Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study.

Autor: Aggerholm-Pedersen N; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. ninnpede@rm.dk., Jellesmark Thorsen LB; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Møller Tauber N; Unit for Psychooncology and Health Psychology, Department of Psychology and Behavioural Science, Aarhus University, Aarhus, Denmark., Tingdal Danielsen J; Unit for Psychooncology and Health Psychology, Department of Psychology and Behavioural Science, Aarhus University, Aarhus, Denmark., Løppenthin K; Department of Oncology, Rigshospitalet, København, Denmark., Borgquist S; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Johansen C; Center for Surgery and Cancer, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Center Late Effect Research, Oncology Clinic, Copenhagen, Denmark., Zacharie R; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Unit for Psychooncology and Health Psychology, Department of Psychology and Behavioural Science, Aarhus University, Aarhus, Denmark.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Jun 30; Vol. 63, pp. 518-525. Date of Electronic Publication: 2024 Jun 30.

A validated algorithm for register-based identification of patients with recurrence of breast cancer-Based on Danish Breast Cancer Group (DBCG) data.

Autor: Aagaard Rasmussen L; Research Centre for Cancer Diagnosis in Primary Care (CaP), Research Unit for General Practice, Bartholins Allé 2, 8000 Aarhus C, Denmark; Department of Public Health, Aarhus University, Bartholins Allé 2, 8000 Aarhus C, Denmark. Electronic address: linda.rasmussen@ph.au.dk., Jensen H; Research Centre for Cancer Diagnosis in Primary Care (CaP), Research Unit for General Practice, Bartholins Allé 2, 8000 Aarhus C, Denmark., Flytkjær Virgilsen L; Research Centre for Cancer Diagnosis in Primary Care (CaP), Research Unit for General Practice, Bartholins Allé 2, 8000 Aarhus C, Denmark., Jellesmark Thorsen LB; Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark; Department of Oncology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark., Vrou Offersen B; Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark; Department of Oncology, Aarhus University Hospital, Noerrebrogade 44, 8000 Aarhus C, Denmark., Vedsted P; Research Centre for Cancer Diagnosis in Primary Care (CaP), Research Unit for General Practice, Bartholins Allé 2, 8000 Aarhus C, Denmark.

Publikováno v: Cancer epidemiology [Cancer Epidemiol] 2019 Apr; Vol. 59, pp. 129-134. Date of Electronic Publication: 2019 Feb 08.

DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.

Autor: Thorsen LB; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany. liseb@oncology.au.dk., Offersen BV; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Danø H; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Berg M; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Jensen I; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Pedersen AN; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Zimmermann SJ; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Brodersen HJ; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Overgaard M; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany., Overgaard J; Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Marie Overgaard, and Jens Overgaard, Aarhus University Hospital, Aarhus; Hella Danø, Herlev Hospital, Herlev; Martin Berg, Vejle Hospital, Vejle; Ingelise Jensen, Aalborg University Hospital, Aalborg; Anders Navrsted Pedersen, Rigshospitalet, Copenhagen; Sune Jürg Zimmermann, Odense University Hospital, Odense, Denmark; and Hans-Jürgen Brodersen, St Franziskus-Hospital, Flensburg, Germany.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Feb 01; Vol. 34 (4), pp. 314-20. Date of Electronic Publication: 2015 Nov 23.

Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: the DBCG-IMN study.

Autor: Thorsen LB; Department of Experimental Clinical Oncology, Aarhus University Hospital , Aarhus , Denmark., Thomsen MS, Overgaard M, Overgaard J, Offersen BV

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2013 Oct; Vol. 52 (7), pp. 1526-34. Date of Electronic Publication: 2013 Aug 19.

BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.

Autor: Thorsen LB; Department of Pharmacology, Faculty of Health Sciences, Aarhus University, Aarhus C, Denmark., Eskildsen-Helmond Y, Zibrandtsen H, Stasch JP, Simonsen U, Laursen BE

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2010 Nov 25; Vol. 647 (1-3), pp. 147-54. Date of Electronic Publication: 2010 Sep 07.